register

News & Trends - Biotechnology

CSL Behring and Cicada to fund innovation challenge

Health Industry Hub | April 16, 2021 |

Biotech News: As the world’s biggest plasma producer, CSL Behring is looking for innovative new ideas and ways to help meet the growing global demand for plasma-derived Human Immunoglobulin G (IgG). IgG is an antibody that contributes to the body’s immune response.

CSL Behring and Cicada Innovations’ new Plasma Protein Purification Challenge seeks to tackle some of the biggest challenges in plasma protein production, and to save and improve lives.

According to the company, there is a global shortage of plasma-derived IgG, leaving many patients unable to access essential treatments. The demand for life-saving IgG therapies continues to grow rapidly in parallel to our global population, making its production a matter of life or death for many.

Douglas Lee, Senior Vice President Global Plasma Product Development of CSL Behring, said “I’m excited about the opportunity to work with many people at one time and to come up with new ideas in this crowdsourced ideation process. It’s an opportunity to glean and harvest those ideas that and get the voices of people that we might not necessarily hear from.”

CSL Behring’s Laura Keigher, Senior Manager Breakthrough Launchpad, commented “We are extending our innovation beyond CSL and opening this challenge to the broader community so that we can increase the number of novel approaches and perspectives that are put before us and open the door to innovators from around the world who might otherwise not have direct access to present their ideas and concepts.”

Two cash prizes are available, with first place being awarded AUD$40,000 and the runner up being awarded $15,000; both winners will receive mentorship from CSL Behring and Cicada Innovations and a direct pathway to one of the world’s leading global biotech companies.

The global challenge is open to entrepreneurs, researchers, engineers and academics. The ambitious and innovative ideas sought will be assessed by a panel of judges on:

  • Innovation: impact and uniqueness of solution
  • Technical feasibility: conceptually and technically sound
  • Commercial feasibility: scalable and cost-efficient
  • Team: credibility and capabilities

Applications close 25 May 2021. Apply here.


Human Resources

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Health Industry Hub | May 20, 2024 |

People & Culture: Coinciding with International HR Day, Karen Newell, Senior HR Director for ANZ at Medtronic, joined Health Industry […]

More


News & Trends - MedTech & Diagnostics

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: An Australian-based medtech company announced promising results from the first-in-human study for its pulsed field ablation […]

More


News & Trends - MedTech & Diagnostics

Federal budget delivers 'mixed news' for radiologists

Federal budget delivers ‘mixed news’ for radiologists

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: The Royal College of Australian and New Zealand Radiologists (RANZCR) and the Interventional Radiology Society of […]

More


News & Trends - Pharmaceuticals

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

Health Industry Hub | May 20, 2024 |

Pharma News: The Senate Community Affairs References Committee has released its inquiry report into Equitable access to diagnosis and treatment […]

More


This content is copyright protected. Please subscribe to gain access.